Home › Calculator › CASBF Dividend Calculator 2026
CASBF Dividend DRIP Calculator 2026
3.80% YieldHealthcareCanSino Biologics Inc. · OTC
Price: $3.15 · Annual div: $0.12/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CASBF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CASBF snowball 📈
$10,000 in CASBF → $10.37M in 10 years · $0.03/month
About CanSino Biologics Inc. (CASBF) — Dividend Analysis 2026
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People's Republic of China.
Compare CASBF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CASBF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CASBF position with:
🌍 CASBF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CASBF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.80% | 1.00% | $380 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 3.23% | 0.43% | $323 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 3.04% | 0.24% | $304 / yr |
| 🇬🇧 UK ISA | 0% | 3.80% | 1.00% | $380 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.47% | 0.67% | $347 / yr |
| 🇨🇦 TFSA | 0% | 3.80% | 1.00% | $380 / yr |
| 🇨🇦 CA Taxable | 25% | 2.85% | 0.05% | $285 / yr |
| 🇦🇺 Super (pension) | 15% | 3.23% | 0.43% | $323 / yr |
| 🇦🇺 AU Taxable | 30% | 2.66% | -0.14% | $266 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.80% | -0.00% | $280 / yr |
| 🇫🇷 FR Taxable | 30% | 2.66% | -0.14% | $266 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CASBF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.12/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CASBF Dividend Payment Schedule
CASBF pays quarterly — 4 times per year. Next ex-div: TBD.
📊 CASBF vs Healthcare Benchmarks
How CASBF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CASBF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CASBF Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CASBF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
CanSino Biologics Inc. (CASBF) is currently trading at $3.15, 94% below its 52-week high. The current dividend yield is 3.80% based on an annual payout of $0.12 per share.
CASBF (CanSino Biologics Inc.) — 3.80% Dividend Yield Analysis
CanSino Biologics Inc. (CASBF) is a healthcare stock currently trading at $3.15 with a dividend yield of 3.80%. The company pays an annual dividend of $0.12 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, CASBF has grown its dividend at a compound annual rate of 50.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.